CIK 0001607678
- Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461073877
- Phone
- +1 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-26 | LIGAND PHARMACEUTICALS INC 10% owner | Sale | −148,700 | $8.11 | $1.2M | 5,819,383 |
| 2020-08-26 | LIGAND PHARMACEUTICALS INC 10% owner | Sale | −94,488 | $8.11 | $766K | 5,819,383 |
| 2020-08-25 | LIGAND PHARMACEUTICALS INC 10% owner | Sale | −70,000 | $8.02 | $562K | 5,968,083 |
| 2018-09-25 | LIGAND PHARMACEUTICALS INC 10% owner | Sale | −262,881 | $19.15 | $5.0M | 6,038,083 |
| 2018-05-21 | LIGAND PHARMACEUTICALS INC 10% owner | Other disposition · Convertible Note (convertible into Common Stock) | −1,916,509 | $1,916,509.00 | $3673.0B | 0 |
| 2017-07-13 | LIGAND PHARMACEUTICALS INC 10% owner | Other disposition · Convertible Note (convertible into Common Stock) | −38,630 | $38,630.00 | $1.5B | 1,916,509 |
| 2016-04-13 | LIGAND PHARMACEUTICALS INC 10% owner | Grant or award | +560,000 | 5,340,964 | ||
| 2016-04-13 | LIGAND PHARMACEUTICALS INC 10% owner | Conversion | +960,000 | $1.25 | $1.2M | 6,300,964 |
| 2016-04-13 | LIGAND PHARMACEUTICALS INC 10% owner | Grant or award · Warrant (right to buy) | +560,000 | 560,000 | ||
| 2016-04-13 | LIGAND PHARMACEUTICALS INC 10% owner | Conversion · Convertible Note (convertible into Common Stock) | −600,000 | $1.25 | $750K | 2,105,139 |
| 2016-04-13 | LIGAND PHARMACEUTICALS INC 10% owner | Conversion · Warrant (right to buy) | +960,000 | 1,520,000 | ||
| 2016-04-13 | LIGAND PHARMACEUTICALS INC 10% owner | Other disposition · Convertible Note (convertible into Common Stock) | −150,000 | $150,000.00 | $22.5B | 1,955,139 |
| 2015-05-28 | LIGAND PHARMACEUTICALS INC 10% owner | Other acquisition | +228,105 | 4,780,964 |
Page 1 of 1 · 13 trades